WGS Revenue Flow Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
2026-06-30: Revenue $114.44M ; Cost of revenue $36.20M ; Research and development $19.66M ; Selling, general and administrative $76.04M . 2026-03-31: Revenue $102.25M ; Cost of revenue $34.04M ; Research and development $19.80M ; Selling, general and administrative $74.59M . 2025-12-31: Revenue $120.99M* ; Cost of revenue $36.72M* ; Research and development $24.54M* ; Selling, general and administrative (m) . 2025-09-30: Revenue $116.74M ; Cost of revenue $32.22M ; Research and development $19.83M ; Selling, general and administrative (m) . Product or service Separate filed amounts; connecting flows are not established. Components and totals may overlap.
WGS revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Product And Service Other $2.55M Diagnostic Test Institutional Customers $16.12M Diagnostic Test $111.89M Diagnostic Test Self Pay $1.04M Diagnostic Test Third Party Insurance $94.73M Revenue $114.44M Cost of revenue $36.20M Gross profit $78.24M Operating income -$17.46M Other income, net $162.00K Research & development $19.66M Selling, general & administrative $76.04M Pre-tax income -$18.26M Net income -$17.74M
Segment Separate filed amounts; connecting flows are not established. Components and totals may overlap.
WGS revenue flow Filed amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow. Gene Dx Segment $114.44M Revenue $114.44M Cost of revenue $36.20M Gross profit $78.24M Operating income -$17.46M Other income, net $162.00K Research & development $19.66M Selling, general & administrative $76.04M Pre-tax income -$18.26M Net income -$17.74M
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown Revenue and expense 3 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Income tax Net income 2026-06-30 $114.44M $36.20M $19.66M $76.04M -$518.00K -$17.74M 2026-03-31 $102.25M $34.04M $19.80M $74.59M $897.00K -$63.32M 2025-12-31 $120.99M* $36.72M* $24.54M* (m) -$564.00K* -$17.64M* 2025-09-30 $116.74M $32.22M $19.83M (m) $247.00K -$7.63M 2025-06-30 $102.69M $31.79M $15.08M $46.86M -$246.00K $10.81M 2025-03-31 $87.11M $28.64M $12.58M $50.45M $447.00K -$6.53M 2024-09-30 $76.87M $29.05M $11.66M (m) -$47.00K -$8.31M 2024-06-30 $70.51M $27.56M $10.90M (m) -$190.00K -$29.17M 2024-03-31 $62.42M $25.01M $11.57M (m) -$82.00K -$20.24M 2023-09-30 $53.30M $28.04M $14.29M (m) -$172.00K -$42.29M 2023-06-30 $48.71M $29.95M $17.14M (m) -$196.00K -$46.72M 2023-03-31 $43.14M $27.90M $14.59M (m) -$147.00K -$60.99M 2022-09-30 $83.23M $69.69M $13.35M (m) -$65.00K -$77.58M 2022-06-30 $36.17M $65.77M $27.17M (m) -$49.08M -$85.74M 2022-03-31 $53.94M $48.32M $21.32M (m) $0.00 -$76.90M 2021-12-31 $57.80M $60.61M $22.25M (m) (m) -$40.19M 2021-09-30 $43.18M $51.49M $17.83M (m) $0.00 $32.73M 2021-06-30 $47.02M $48.18M $11.95M (m) $0.00 -$46.16M 2021-03-31 $64.20M $68.52M $53.13M (m) $0.00 -$191.78M 2020-12-31 $63.96M $69.63M $31.16M (m) (m) -$125.68M 2020-09-30 $38.61M $34.02M $19.08M (m) $0.00 -$56.62M 2020-06-30 $30.10M $34.51M $9.36M (m) (m) -$32.05M 2020-03-31 $46.66M $37.14M $13.10M (m) (m) -$26.99M
Revenue and expense 6 month Period end Revenue Cost of revenue Research and development Selling, general and administrative Income tax Net income 2026-06-30 $216.69M $70.25M $39.46M $150.63M $379.00K -$81.06M 2025-06-30 $189.81M $60.43M $27.66M $97.31M $201.00K $4.28M 2024-06-30 $132.94M $52.57M $22.47M (m) -$272.00K -$49.41M 2023-06-30 $91.84M $57.85M $31.73M (m) -$343.00K -$107.71M 2022-06-30 $90.11M $114.08M $48.48M (m) -$49.08M -$162.64M 2021-06-30 $111.22M $116.70M $65.08M (m) $0.00 -$237.94M 2020-12-31 (m) (m) (m) (m) (m) -$39.91M
Revenue and expense 9 month Period end Revenue Cost of revenue Research and development Income tax Net income 2025-09-30 $306.55M $92.64M $47.48M $448.00K -$3.35M 2024-09-30 $209.81M $81.62M $34.13M -$319.00K -$57.72M 2023-09-30 $145.15M $85.90M $46.02M -$515.00K -$149.99M 2022-09-30 $173.34M $183.77M $61.84M -$49.14M -$240.22M 2021-09-30 $154.39M $168.19M $82.92M $0.00 -$205.21M 2020-09-30 $115.36M $111.75M $41.54M $0.00 -$115.66M
Revenue and expense 12 month Period end Revenue Cost of revenue Research and development Income tax Net income 2025-12-31 $427.54M $129.37M $72.03M -$116.00K -$21.00M 2024-12-31 $305.45M $111.05M $45.72M -$343.00K -$52.30M 2023-12-31 $202.57M $112.56M $58.27M -$926.00K -$175.80M 2022-12-31 $234.69M $261.44M $86.20M -$49.05M -$548.98M 2021-12-31 $212.19M $228.80M $105.16M $0.00 -$245.39M 2020-12-31 $179.32M $175.30M $72.70M $0.00 -$241.34M 2019-12-31 $196.17M $113.39M $34.91M $0.00 -$29.70M